Cargando…

Recent update on barbiturate in relation to brain disorder

Detalles Bibliográficos
Autores principales:	Pathak, Sachchidanand, Gupta, Gaurav, Thangavelu, Lakshmi, Singh, Sachin K., Dua, Kamal, Chellappan, Dinesh Kumar, Gilhotra, Ritu M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278211/ https://www.ncbi.nlm.nih.gov/pubmed/34267614 http://dx.doi.org/10.17179/excli2021-3687

Ejemplares similares

Recent updates on daidzein against oxidative stress and cancer
por: Rawat, Sarita, et al.
Publicado: (2019)

Current biological and pharmacological updates on wogonin
por: Rawat, Sarita, et al.
Publicado: (2020)

Preventive role of Sapindus species in different neurological and metabolic disorders
por: Rawat, Sarita, et al.
Publicado: (2022)

Emerging prospects of vitamin D3 in metabolic syndrome: A proof of concept (POC) approach targeting inflammation
por: Singh, Yogendra, et al.
Publicado: (2020)

Current update on the protective effect of naringin in inflammatory lung diseases
por: Gupta, Gaurav, et al.
Publicado: (2022)

Recent updates on neuropharmacological effects of luteolin
por: Gupta, Gaurav, et al.
Publicado: (2018)

Cytotoxic mechanisms of berberine-phytantriol liquid crystalline nanoparticles against non-small-cell lung cancer
por: Paudel, Keshav Raj, et al.
Publicado: (2023)

Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-?B pathway in the pathogenesis of cancer
por: Gupta, Gaurav, et al.
Publicado: (2021)

Recent update on biological activities and pharmacological actions of liraglutide
por: Tiwari, Juhi, et al.
Publicado: (2017)

Recent developments in the role of protocatechuic acid in neurodegenerative disorders
por: Thapa, Riya, et al.
Publicado: (2023)

Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures
por: Gupta, Gaurav, et al.
Publicado: (2017)

Current update on the protective effect of epicatechin in neurodegenerative diseases
por: Thapa, Riya, et al.
Publicado: (2022)

Emerging Paradigms in Bioengineering the Lungs
por: Mohgan, Raxshanaa, et al.
Publicado: (2022)

Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells
por: Jackson, Kiren, et al.
Publicado: (2020)

COVID-19 in underlying COPD Patients
por: Sunkara, Krishna, et al.
Publicado: (2021)

Female gender as a risk factor for developing COPD
por: Shukla, Shakti D., et al.
Publicado: (2021)

Nanomedicine and medicinal plants: Emerging symbiosis in managing lung diseases and associated infections
por: Paudel, Keshav Raj, et al.
Publicado: (2022)

Interferon therapy for preventing COPD exacerbations
por: Mehta, Meenu, et al.
Publicado: (2020)

Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis
por: Chan, Yinghan, et al.
Publicado: (2020)

Data on known anti-virals in combating CoVid-19
por: Akshayaa, L, et al.
Publicado: (2020)

Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanisms
por: Prasher, Parteek, et al.
Publicado: (2023)

Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives
por: Pattanayak, Prapti, et al.
Publicado: (2021)

The versatility of 18ß-glycyrrhetinic acid in attenuating pulmonary inflammatory disorders
por: Mohamad, Mohamad Siddiq Bin, et al.
Publicado: (2023)

The Therapeutic Use of Barbiturates
por: Clark, A. J.
Publicado: (1938)

Synthesis and structure of push–pull merocyanines based on barbituric and thiobarbituric acid
por: Bogdanov, Georgii, et al.
Publicado: (2019)

Adenocarcinoma - success so far and the way ahead
por: Fatima, Rabab, et al.
Publicado: (2023)

Anticancer effects and lysosomal acidification in A549 cells by Astaxanthin from Haematococcus lacustris
por: Ramamoorthy, K, et al.
Publicado: (2020)

Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
por: Mehta, Meenu, et al.
Publicado: (2019)

Efficacy of a Novel Prophylactic Barbiturate Therapy for Severe Traumatic Brain Injuries: Step-down Infusion of a Barbiturate with Normothermia
por: KAJIWARA, Sosho, et al.
Publicado: (2021)

Gut Dysbiosis and Diabetic Foot Ulcer: Role of Probiotics
por: Awasthi, Ankit, et al.
Publicado: (2022)

Barbiturate Poisoning Treated with Picrotoxin
por: Konar, N. R., et al.
Publicado: (1950)

Prolonged Coma in Barbiturate Poisoning
por: Matts, S. G. Flavell, et al.
Publicado: (1959)

Pharmacological Evaluation of Antidepressant-Like Effect of Genistein and Its Combination with Amitriptyline: An Acute and Chronic Study
por: Gupta, Gaurav, et al.
Publicado: (2015)

Vesicular drug-delivery systems as theranostics in COVID-19
por: Satija, Saurabh, et al.
Publicado: (2020)

Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives
por: Panthi, Vijay Kumar, et al.
Publicado: (2023)

Barbiturates for the treatment of intracranial hypertension after traumatic brain injury
por: Bassin, Sarice L, et al.
Publicado: (2008)

Advances in Lung Cancer Treatment Using Nanomedicines
por: Sharma, Akshansh, et al.
Publicado: (2022)

A molecular study of aryl hydrocarbon receptor activation in COVID 19 associated cognitive impairment – Correspondence
por: Singh, Yogendra, et al.
Publicado: (2022)

Biochemical study of monkeypox zoonotic disease associated human skin dysbiosis and soft tissue injury – Correspondence
por: Singh, Yogendra, et al.
Publicado: (2022)

A novel nano therapeutic using convalescent plasma derived exosomal (CP(Exo)) for COVID-19: A combined hyperactive immune modulation and diagnostics
por: Anand, Krishnan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jbguhbqi3tshsjm9is3emkno6h